bpc-157 human evidence clinical trials FDA Approval Status: Is It Approved for Use? bpc-157 human clinical trials evidence
Description
doi:10.3390/ph12030185
Penetration is limited compared to injection, but topical application is still clinically meaningful for surface skin remodeling when used consistently
Mislabeling, repurposing or unauthorized use violates regulatory requirements and can result in serious legal consequences for the institution
No cases of Bell's palsy were reported in the placebo group
